First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
Berenberg Bank analyst Kerry Holford maintained a Buy rating on Barry Callebaut AG (BARN – Research Report) on January 24 and set a price ...
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from ...
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...
This European review of the prefilled syringe follows GSK's receipt of approval from the US Food & Drug Administration on January 8. GSK is also investigating submission of the new presentation to ...
(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback